261 related articles for article (PubMed ID: 8862512)
1. Molecular oncology in pancreatic cancer.
Gansauge S; Gansauge F; Beger HG
J Mol Med (Berl); 1996 Jun; 74(6):313-20. PubMed ID: 8862512
[TBL] [Abstract][Full Text] [Related]
2. Molecular prognostic markers in pancreatic cancer.
Ghaneh P; Kawesha A; Evans JD; Neoptolemos JP
J Hepatobiliary Pancreat Surg; 2002; 9(1):1-11. PubMed ID: 12021893
[TBL] [Abstract][Full Text] [Related]
3. Role of tumour markers, cytogenetics.
Lamerz R
Ann Oncol; 1999; 10 Suppl 4():145-9. PubMed ID: 10436809
[TBL] [Abstract][Full Text] [Related]
4. Molecular pattern of ductal pancreatic cancer.
Sirivatanauksorn V; Sirivatanauksorn Y; Lemoine NR
Langenbecks Arch Surg; 1998 Apr; 383(2):105-15. PubMed ID: 9641882
[TBL] [Abstract][Full Text] [Related]
5. Molecular biology of exocrine pancreatic cancer.
Soto JL; Barbera VM; Saceda M; Carrato A
Clin Transl Oncol; 2006 May; 8(5):306-12. PubMed ID: 16760004
[TBL] [Abstract][Full Text] [Related]
6. [Tumour markers of pancreatic cancer--Part II (molecular markers of carcinogenesis and non-specific tumour markers)].
Groblewska M; Mroczko B; Karpiuk E; Szmitkowski M
Pol Arch Med Wewn; 2005 Nov; 114(5):1118-27. PubMed ID: 16789513
[No Abstract] [Full Text] [Related]
7. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.
van Es JM; Polak MM; van den Berg FM; Ramsoekh TB; Craanen ME; Hruban RH; Offerhaus GJ
J Clin Pathol; 1995 Mar; 48(3):218-22. PubMed ID: 7730480
[TBL] [Abstract][Full Text] [Related]
9. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers of pancreatic cancer: development and clinical relevance.
Fry LC; Mönkemüller K; Malfertheiner P
Langenbecks Arch Surg; 2008 Nov; 393(6):883-90. PubMed ID: 18266003
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
12. Serum tumor markers and molecular biological diagnosis in pancreatic cancer.
Sawabu N; Watanabe H; Yamaguchi Y; Ohtsubo K; Motoo Y
Pancreas; 2004 Apr; 28(3):263-7. PubMed ID: 15084968
[TBL] [Abstract][Full Text] [Related]
13. Multi-step pancreatic carcinogenesis and its clinical implications.
Sakorafas GH; Tsiotou AG
Eur J Surg Oncol; 1999 Dec; 25(6):562-5. PubMed ID: 10555999
[TBL] [Abstract][Full Text] [Related]
14. [Pancreatic carcinogenesis. Clinical implications].
Schneider G; Lersch C; Schmid RM
Chirurg; 2003 Mar; 74(3):165-70. PubMed ID: 12647072
[TBL] [Abstract][Full Text] [Related]
15. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
[TBL] [Abstract][Full Text] [Related]
16. [The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers].
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):741-4. PubMed ID: 16255879
[TBL] [Abstract][Full Text] [Related]
17. [Recent advances in gene change of pancreatic cancer].
Wang YY; Cui QC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
[TBL] [Abstract][Full Text] [Related]
18. Expression of oncogene products, anti-oncogene products and oncofetal antigens in intraductal papillary-mucinous neoplasm of the pancreas.
Terada T; Ohta T; Nakanuma Y
Histopathology; 1996 Oct; 29(4):355-61. PubMed ID: 8910043
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of pancreatic cancer.
Hamada S; Shimosegawa T
Pancreatology; 2011; 11 Suppl 2():14-9. PubMed ID: 21464582
[TBL] [Abstract][Full Text] [Related]
20. Ductal and acinar differentiation in pancreatic endocrine tumors.
Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M; Yamaguchi T
Dig Dis Sci; 2002 Oct; 47(10):2254-61. PubMed ID: 12395898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
